Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release
Part of paid clinical trials in Fairborn, Ohio.
- Sponsor
- Wright State University
- Study ID
- NCT07640061
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Microvesicle Particles
- Thermal Burn
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Amitriptyline — DRUG75mg amitriptyline
- Placebo — DRUGPlacebo
Study Details
The purpose of this study is to determine the amount of substances contained in skin known as microvesicle particles (MVP). The hypothesis to be tested in this study is that treatment with a single dose of 75mg of amitriptyline will block the MVP released from the skin from a very small localized burn injury.
Key Dates
- Start date
- Jun 30, 2027
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2033
- Completion
- Jun 30, 2033
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Other: Amitriptyline then PlaceboAt Visit 1, subjects take 75mg amitriptyline. Then at Visit 2, subjects take a placebo.
- Other: Placebo then AmitriptylineAt Visit 1, subjects take placebo. Then at Visit 2, subjects take 75mg amitriptyline.
Primary Outcome Measure
Change from Baseline in MVP Release in Skin from a localized thermal burn injury in response to oral amitriptyline versus placebo as measured by skin biopsy [ Time Frame: 2 hours after the burn injury ]
Central Contacts
- Pharmacology Translational Unit937-245-7500
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wright State University - Pharmacology Translational Unit | Fairborn | Ohio | 45324 |
Find similar trials in Fairborn, OH
Related Studies
- Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to AutograftingPHASE3 · Recruiting · XenoTherapeutics, Inc. · Phoenix, Arizona
- Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) TrialPHASE3 · Not Yet Recruiting · Jason Sperry · Pittsburgh, Pennsylvania